/Investor DB

Amgen Ventures — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRAOct 2021

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more

Genome Medicalgenomemedical.comin𝕏Aug 2021

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in

Co-investorsAlumni VenturesAvestria VenturesBlue Ivy VenturesCanaan PartnersDreamers VCEcho Health Ventures+13 more

Hummingbirdhummingbird-tech.comMay 2021

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOxford Investment Opportunity Network (OION)Ally Bridge GroupAltium CapitalDroia VenturesFrazier Healthcare PartnersNovo Holdings+2 more

Hummingbird Biosciencehummingbirdbioscience.comin𝕏May 2021

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in

Co-investorsAltium CapitalClavystBioDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom Investment+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Akili Interactive Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.